[Form 4] PROGRESS SOFTWARE CORP /MA Insider Trading Activity

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Progress Software’s Chief Legal Officer, Stephanie Yufan Wang, reported selling a total of 5,019 shares of common stock on May 18, 2026 in open-market transactions. The sales were executed in tranches at weighted average prices of $28.44 and $29.04 per share.

According to the disclosure, these transactions were carried out under a preexisting Rule 10b5-1 trading plan adopted on January 23, 2026, described as established prior to recent volatility in the company’s stock price and in compliance with applicable laws and regulations. Each tranche consisted of multiple trades within stated price ranges.

Insights

Pre-planned, modest insider stock sale under a Rule 10b5-1 plan.

Stephanie Yufan Wang, Chief Legal Officer of Progress Software, sold 5,019 shares of common stock on May 18, 2026. The transactions were open-market sales at weighted average prices of $28.44 and $29.04 per share.

The filing states the sales occurred pursuant to a preexisting Rule 10b5-1 trading plan adopted on January 23, 2026, before recent stock price volatility. Such plans pre-schedule trades, which typically makes the timing less indicative of the insider’s short-term view of the stock.

The report shows only non-derivative stock sales, with no option exercises or new grants in this filing and no remaining derivative positions listed. The overall economic impact appears limited based on the disclosed share count, and the transactions are best viewed as routine, pre-planned liquidity rather than a thesis-changing event.

Insider Trade Summary 10b5-1

Net Seller: 5,019 shares ($144,852)

Net Sell 2 txns

Insider WANG YUFAN STEPHANIE

Role Chief Legal Officer

Sold 5,019 shs ($145K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,500	$28.44	$43K
Sale	Common Stock	3,519	$29.04	$102K

Holdings After Transaction: Common Stock — 6,063 shares (Direct, null)

Footnotes (1)

The sale reported in this Form 4 was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the Reporting Person on January 23, 2026, prior to the recent volatility in the Company's stock price and in compliance with all applicable laws and regulations. The sale is reported on two rows due to being executed in multiple trades across a price range that exceeded $1. This tranche of the sale was executed in multiple trades at prices ranging from $27.83 to $28.77 per share. The price reported represents the weighted average sale price of these trades. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. This tranche of the sale was executed in multiple trades at prices ranging from $28.84 to $29.21 per share. The price reported represents the weighted average sale price of these trades. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.

Key Figures

Shares sold total: 5,019 shares Weighted average sale price (tranche 1): $28.44/share Weighted average sale price (tranche 2): $29.04/share +3 more

6 metrics

Shares sold total 5,019 shares Common stock sold on May 18, 2026

Weighted average sale price (tranche 1) $28.44/share 1,500-share tranche on May 18, 2026

Weighted average sale price (tranche 2) $29.04/share 3,519-share tranche on May 18, 2026

Price range tranche 1 $27.83–$28.77 Multiple trades within this range

Price range tranche 2 $28.84–$29.21 Multiple trades within this range

10b5-1 plan adoption date January 23, 2026 Preexisting trading plan for reported sales

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open-market sale, non-derivative, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The sale reported in this Form 4 was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the Reporting Person..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported represents the weighted average sale price of these trades."

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

non-derivative financial

"transaction_type: "non-derivative""

volatility in the Company's stock price financial

"prior to the recent volatility in the Company's stock price and in compliance with all applicable laws and regulations."

Form 4 Insider Transactions: What Each Field Means →

05/20/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WANG YUFAN STEPHANIE

(Last)

(First)

(Middle)

C/O PROGRESS SOFTWARE CORPORATION

15 WAYSIDE ROAD, SUITE 400

(Street)

BURLINGTON

MASSACHUSETTS

01803

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROGRESS SOFTWARE CORP /MA [ PRGS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/18/2026		S⁽¹⁾		1,500	D	$28.44⁽²⁾	6,063	D
Common Stock	05/18/2026		S⁽¹⁾		3,519	D	$29.04⁽³⁾	2,544	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the Reporting Person on January 23, 2026, prior to the recent volatility in the Company's stock price and in compliance with all applicable laws and regulations. The sale is reported on two rows due to being executed in multiple trades across a price range that exceeded $1.

2. This tranche of the sale was executed in multiple trades at prices ranging from $27.83 to $28.77 per share. The price reported represents the weighted average sale price of these trades. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.

3. This tranche of the sale was executed in multiple trades at prices ranging from $28.84 to $29.21 per share. The price reported represents the weighted average sale price of these trades. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.

Remarks:

	YuFan Stephanie Wang	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Progress Software (PRGS) disclose in this Form 4?

Progress Software disclosed that Chief Legal Officer Stephanie Yufan Wang sold 5,019 shares of common stock on May 18, 2026. The sales were open-market transactions at weighted average prices of $28.44 and $29.04 per share, as reported across two tranches.

Who is the insider involved in the latest PRGS Form 4 filing?

The insider is Stephanie Yufan Wang, the Chief Legal Officer of Progress Software. She is identified as an officer, not a director or 10% owner, and reported selling common stock in open-market transactions under a preexisting Rule 10b5-1 trading plan.

How many Progress Software (PRGS) shares were sold and at what prices?

The filing reports total sales of 5,019 Progress Software common shares. One tranche of 1,500 shares had a weighted average price of $28.44 per share, and another tranche of 3,519 shares had a weighted average price of $29.04 per share.

Were the PRGS insider stock sales made under a Rule 10b5-1 trading plan?

Yes. The Form 4 states that the sales were effected pursuant to a preexisting Rule 10b5-1 trading plan adopted on January 23, 2026. The filing notes this plan was adopted before recent volatility in Progress Software’s stock price and complies with applicable laws.

What price ranges did the PRGS insider sales cover on May 18, 2026?

The filing explains that one tranche was executed in multiple trades between $27.83 and $28.77 per share, while the other tranche ranged from $28.84 to $29.21 per share. Each reported price represents the weighted average sale price for the respective tranche.

Does the Form 4 show any PRGS option exercises or derivative transactions?

No. The transaction data and derivative summary show only non-derivative sales of common stock and no option exercises or other derivative transactions. The derivativeSummary field is empty, indicating no remaining derivative positions are reported in this filing.